Journal of Epidemiology and Global Health

<Previous Article In Issue
Next Article In Issue>
Volume 6, Issue 4, December 2016, Pages 315 - 323

Risk factors and quality of life of dyslipidemic patients in Lebanon: A cross-sectional study

Authors
Akram Farhat, Amal Al-Hajje, Samar Rachidi, Salam Zein, Mayssam Bou Zeid, Pascale Salameh, Wafaa Bawab, Sanaa Awada*, s.awada@ul.edu.lb sanaa3a@hotmail.comcom
Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Lebanese University, Hadath, Lebanon
*Corresponding author. Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Lebanese University, Rafic Hariri Campus, Hadath, Lebanon.
Corresponding Author
Received 19 March 2016, Revised 22 July 2016, Accepted 19 October 2016, Available Online 11 November 2016.
DOI
10.1016/j.jegh.2016.10.001How to use a DOI?
Keywords
Dyslipidemia; Lebanese population; Quality of life; SF-36
Abstract

The main objective of this study was to identify the risk factors of dyslipidemia and measure its impact on patients’ quality of life (QOL). Secondary objectives were to determine the percentage of dyslipidemia and assess the predictive factors affecting patients’ QOL. A cross-sectional study was conducted in a sample of Lebanese population. A standardized questionnaire was developed to assess the QOL using the Short form-36 (SF-36) score. A total of 452 individuals were interviewed, of which 59.5% were females. The mean age was 43.3 ± 15.6 years, and 24.8% had dyslipidemia. The results show a lower overall QOL score among dyslipidemic patients compared with controls (57.9% and 76.5%, respectively; p < 0.001). Waterpipe smoking [adjusted odds ratio (ORa) = 4.113, 95% confidence interval (CI): 1.696–9.971, p = 0.002], hypertension (ORa = 3.597, 95% CI: 1.818–7.116, p < 0.001), diabetes (ORa = 3.441, 95% CI: 1.587–7.462, p = 0.002), cigarette smoking (ORa = 2.966, 95% CI: 1.516–5.804, p = 0.001), and passive smoking (ORa = 2.716, 95% CI: 1.376–5.358, p = 0.004) were significantly associated with dyslipidemia in individuals older than 30 years. A higher overall QOL score (p = 0.013) was observed in patients treated with statins in comparison with other lipid-lowering medications. In addition to clinical and economical consequences, dyslipidemia may have a significant impact on patients’ QOL. Further research is needed to confirm the impact of treatment on dyslipidemic patients’ QOL in order to maximize the overall benefits of therapy.

Copyright
© 2016 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
Open Access
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Download article (PDF)
View full text (HTML)

<Previous Article In Issue
Next Article In Issue>
Journal
Journal of Epidemiology and Global Health
Volume-Issue
6 - 4
Pages
315 - 323
Publication Date
2016/11/11
ISSN (Online)
2210-6014
ISSN (Print)
2210-6006
DOI
10.1016/j.jegh.2016.10.001How to use a DOI?
Copyright
© 2016 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
Open Access
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Cite this article

risenwbib
TY  - JOUR
AU  - Akram Farhat
AU  - Amal Al-Hajje
AU  - Samar Rachidi
AU  - Salam Zein
AU  - Mayssam Bou Zeid
AU  - Pascale Salameh
AU  - Wafaa Bawab
AU  - Sanaa Awada
PY  - 2016
DA  - 2016/11/11
TI  - Risk factors and quality of life of dyslipidemic patients in Lebanon: A cross-sectional study
JO  - Journal of Epidemiology and Global Health
SP  - 315
EP  - 323
VL  - 6
IS  - 4
SN  - 2210-6014
UR  - https://doi.org/10.1016/j.jegh.2016.10.001
DO  - 10.1016/j.jegh.2016.10.001
ID  - Farhat2016
ER  -